Skip to main navigationSkip to main content
The University of Southampton
Medicine

Dr Adnan H Khan BSc, MB BS, PhD, FRCOphth

NIHR Clinical Lecturer in Ophthalmology

Dr Adnan H Khan's photo

Dr Adnan Khan is the NIHR Clinical Lecturer in Ophthalmology at the University of Southampton. He is undertaking ‘bench-to-bedside’ research into the immunological basis of sight-threatening eye diseases, including Age-Related Macular Degeneration (AMD). He is a clinician-scientist in training, combining research with higher specialty training in ophthalmology.

Adnan joined the University of Southampton in 2019. His passion for medical research developed early at University College London (UCL) Medical School, where he interrupted his medical studies to undertake an intercalated PhD in transplantation immunology with Professors Andrew George MBE and Giovanna Lombardi at Imperial College London. He investigated the use of dendritic cell immunotherapy to induce donor-specific transplantation tolerance. Adnan demonstrated that dendritic cells (the body’s ‘professional’ antigen-presenting cells), when modified using lentiviral vectors to inhibit co-stimulation, or ‘signal 2’ to alloreactive T cells, can prevent corneal graft rejection. This was mediated by the generation of antigen-specific regulatory T cells (Tregs). The research was funded by the Roche Organ Transplantation Research Foundation (ROTRF), a registered medical research charity based in Switzerland. Adnan was awarded The Transplantation Society (TTS) International Young Investigator Award in 2008 for this work.

Adnan undertook further research in transplantation immunology as an Academic Foundation Doctor in Professor Kathryn Wood’s Transplantation Research Immunology Group (TRIG) before entering Ophthalmology training in Scotland. In Aberdeen, he became a co-investigator of an ophthalmology clinical trial, working together with a team of clinician-scientists.

He is currently working with Professor Andrew Lotery at the University of Southampton to elucidate the inflammatory mechanisms underlying the development of Age-Related Macular Degeneration (AMD). AMD is predicted to affect 288 million people worldwide by 2040, with no curative treatments currently available for this progressive disease that results in loss of central vision.

Qualifications

Appointments held

Research interests

There is increasing evidence that the dysregulation of immune responses has a role in the progression of age-related macular degeneration (AMD). With increasing age, there is a general decline in the immune system and thymic function, termed immunosenescence. This phenomenon is believed to result in an increased susceptibility to infections, cancer and autoimmune diseases with ageing.

Adnan’s current research interests are the role of immunosenescence, and adaptive immune responses, in the pathogenesis of AMD.

He is supported by the Gift of Sight Charity, Southampton.

Research group

Clinical and Experimental Sciences

Affiliate research group

Clinical Neuroscience Research Group

  • Undergraduate Medicine Programmes (BM)- Admissions Interview Team
  • Undergraduate Medicine Programmes (BM)- Personal Academic Tutor

 

 

Sort via:TypeorYear

Articles

Conferences

Review

Undergraduate Medicine Programmes (BM)- Year 4 Ophthalmology Clinical Instructor

Dr Adnan H Khan
Faculty of Medicine, University of Southampton, Building 85, Life Sciences Building, Highfield Campus, Southampton, SO171BJ

Room Number: SGH/LD72/MP806

Share this profile Share this on Facebook Share this on Twitter Share this on Weibo
Privacy Settings